Butyrylcholinesterase anticorps
-
- Antigène Voir toutes Butyrylcholinesterase (BCHE) Anticorps
- Butyrylcholinesterase (BCHE)
-
Reactivité
- Humain, Souris
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp Butyrylcholinesterase est non-conjugé
-
Application
- ELISA, Immunohistochemistry (IHC)
- Attributs du produit
- Polyclonal Antibody
- Purification
- Antigen affinity purification
- Immunogène
- Fusion protein of human BCHE
- Isotype
- IgG
- Top Product
- Discover our top product BCHE Anticorps primaire
-
-
- Indications d'application
- IHC 1:40-1:200, ELISA 1:5000-1:10000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.6 mg/mL
- Buffer
- PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Antigène
- Butyrylcholinesterase (BCHE)
- Autre désignation
- BCHE (BCHE Produits)
- Synonymes
- anticorps che, anticorps che1, anticorps bche, anticorps cholinesterase, anticorps CHE1, anticorps CHE2, anticorps E1, anticorps C730038G20Rik, anticorps butyrylcholinesterase L homeolog, anticorps butyrylcholinesterase, anticorps bche.L, anticorps bche, anticorps BCHE, anticorps Bche
- Sujet
- Mutant alleles at the BCHE locus are responsible for suxamethonium sensitivity. Homozygous persons sustain prolonged apnea after administration of the muscle relaxant suxamethonium in connection with surgical anesthesia. The activity of pseudocholinesterase in the serum is low and its substrate behavior is atypical. In the absence of the relaxant, the homozygote is at no known disadvantage.
- UniProt
- P06276
- Pathways
- Peptide Hormone Metabolism
-